GALNT9 Antikörper (AA 333-573)
-
- Target Alle GALNT9 Antikörper anzeigen
- GALNT9 (Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9))
-
Bindungsspezifität
- AA 333-573
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GALNT9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- Human GALNT9
- Homologie
- Percent identity by BLAST analysis: Human (100%) Rat (96%) Mouse (95%).
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Recombinant fragment corresponding to a region within amino acids 333 and 573 of GALNT9 (SwissProt Q9HCQ5). Percent identity by BLAST analysis: Human (100%), Rat (96%), Mouse (95%).
Type of Immunogen: Recombinant protein - Isotyp
- IgG
- Top Product
- Discover our top product GALNT9 Primärantikörper
-
anti-Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9) (AA 296-322) antibody
GALNT9 Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB38256 unconjugated
anti-Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9) (AA 1-237) antibodyGALNT9 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
anti-Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9) antibodyGALNT9 Reaktivität: Human, Maus WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9) (AA 138-237) antibodyGALNT9 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9) (AA 1-237) antibodyGALNT9 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
-
- Applikationshinweise
-
Approved: WB (1:500 - 1:3000)
Usage: Suggested starting dilutions are as follows: Western blot: 1:500-1:3000. Not yet tested in other applications. Optimal working dilutions should be determined experimentally by the end user. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
- Target
- GALNT9 (Udp-N-Acetyl-alpha-D-Galactosamine:polypeptide N-Acetylgalactosaminyltransferase 9 (GalNAc-T9) (GALNT9))
- Andere Bezeichnung
- GALNT9 (GALNT9 Produkte)
- Synonyme
- GALNT9 antikoerper, 6430598F23 antikoerper, GalNAc-T9 antikoerper, GALNAC-T9 antikoerper, GALNACT9 antikoerper, polypeptide N-acetylgalactosaminyltransferase 9 antikoerper, GALNT9 antikoerper, LOC710382 antikoerper, LOC749939 antikoerper, galnt9 antikoerper, Galnt9 antikoerper
- Hintergrund
-
Name/Gene ID: GALNT9
Synonyms: GALNT9, GalNAc transferase 9, GALNAC-T9, Pp-GaNTase 9 - Gen-ID
- 50614
- UniProt
- Q9HCQ5
-
